Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Cascader completes a seed funding round led by Topcon Healthcare to advance its ophthalmic artificial intelligence platform. The capital will support the transition of AI technologies into clinical use.

PRIVATESep 23, 2026•about 2 hours ago

Round Type

Seed

United KingdomBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth Diagnostics

Investors

Topcon Healthcare

Description

Cascader, a medical technology company based in the United Kingdom, has completed a seed funding round to advance its ophthalmic artificial intelligence platform. The funding round was led by Topcon Healthcare, which has supported the company since its inception. The capital will help transition its AI technologies into clinical use and support the progression of its initial products toward market launch. Cascader specializes in developing AI tools for the early detection and management of eye diseases.

Company Information

Company

Cascader

Location

United Kingdom

About

Cascader is a medical technology company focused on developing artificial intelligence tools for the early detection and management of eye diseases. The startup aims to transition its AI technologies into clinical use with applications in oculomics and systemic disease diagnostics. Founded as a spinout from Moorfields Eye Hospital NHS Foundation Trust, Topcon Healthcare, and UCL Ventures, Cascader leverages over a decade of research from the UCL Institute of Ophthalmology. The company builds deep learning algorithms to analyze medical imaging for improved disease detection accuracy.

Fundz sees it the moment Cascader raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cascader's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Cascader raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.